Efficacy and safety of port delivery platform with ranibizumab (PDS) for diabetic macular oedema (Pagoda Randomised Clinical Trial) - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Safety and effectiveness of the ranibizumab port delivery system for diabetic macular oedema: the PAGODA randomized clinical trial

  • By

  • Shamika Gune

  • Mel Rabena

  • Ashwini Bobbala

  • October 8, 2026

Share

Original Source(s)

Efficacy and safety of port delivery platform with ranibizumab (PDS) for diabetic macular oedema (Pagoda Randomised Clinical Trial)

  • by Shamika Gune, Mel Rabena, Ashwini Bobbala

  • October 8, 2026

Related Content

Spectacle Lenses With Highly Aspherical Lenslets for Myopia Control: A Randomized Clinical Trial

Repeat surgical interventions in non-Fuchs corneal dystrophies: insights from eight decades of histopathological and clinical data

Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease: The TEASE-1